Omeros reported $-17456000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acelrx Pharmaceuticals ACRX:US USD -6750000 77.41M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Cytokinetics CYTK:US USD -142310000 122.49M
Gilead Sciences GILD:US USD 1.79B 645M
Insmed INSM:US USD -131145000 35.5M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Knight Therapeutics Inc GUD:CN CAD 1.59M 925K
Macrogenics MGNX:US USD -24813000 16.49M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Omeros OMER:US USD -17456000 13.39M
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Pfizer PFE:US USD 5B 3.61B
Regulus Therapeutics RGLS:US USD -7551000 293K
Rockwell Medical RMTI:US USD -4190000 777K
Sangamo Biosciences SGMO:US USD -53155000 9.98M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
United Therapeutics UTHR:US USD 239.3M 123.3M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M
Vital Therapies VTL:US USD -21224000 677K
Xoma XOMA:US USD -4178000 492K